Monitoring blood-based biomarkers as early predictors of progression-free survival in a randomized Bria-ABC phase 3 trial for advanced metastatic breast cancer: An ongoing analysis.

cyclophosphamide - Generic mfg.

Bria-IMT (SV-BR-1-GM) - BriaCell

https://www.asco.org/abstracts-presentations/257893

Daniel Adams; Chaitali Nangia; Adriana Kahn; Lawrence Negret; William Williams; Blaise Bayer; Giuseppe DiPriore; Alexis Duffy; Saranya Chumsri

Apr 21, 2026